Initial delivery of an order for 600 LabPad® Evolution to German distributor IMACO.
On January 8th, 2021, AVALUN delivered a first batch of its newly launched LabPad® Evolution product to its German partner IMACO. With a first order of 600 LabPad® Evolution placed last November, IMACO’s objective is to offer German’s healthcare professional an enhanced solution to help them respond to the COVID-19 pandemic.
About the LabPad® Evolution
LabPad® Evolution is a handheld Point of Care (PoC) multi-measurements testing device, designed to assist healthcare professionals in direct contact with patients, wherever they are. It operates with a range of compatible single-use tests, each test allowing for the performance of a specific biology test. Currently available tests are for SARS-COV2 Antigen and TP/INR rapid tests. A serologic test for SARS-COV2 will follow in Q1, 2021. Next tests to be made available will then be for nutrition and cardiac markers.
Click here for more information about the LabPad Evolution.
For any inquiries, please contact us via e-mail.